Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index, and 1 are not checked yet.

A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients.

Open access
Passik, Steven D, Kirsh, Kenneth L, Theobald, Dale E, Dickerson, Pamela, Trowbridge, Randall, Gray, David, Beaver, Megan, Comparet, Jessica, Brown, Justin · 2003 · Journal of Pain and Symptom Management

Abstract

Chemotherapy-induced delayed emesis (DE) affects approximately 50-70% of patients receiving moderately and highly emetogenic chemotherapy. DE most commonly occurs within the first 24-48 hours of chemotherapy administration and can persist for 2-5 days. Olanzapine, which has been used anecdotally for chronic nausea in advanced cancer patients, might be a useful treatment for the prevention of delayed emesis in chemotherapy patients. We conducted a chart review to explore this hypothesis and to plan potential studies. Using pharmacy records or an electronic medical record, we identified all patients who had received olanzapine in the oncology clinic (n = 98). We reviewed these records and selected all patients (n = 28) who had received olanzapine for the prevention of delayed emesis for structured review. There were 17 women (60.7%) and 11 men (39.3%). Eleven patients (39.3%) had at least one instance of nausea recorded while undergoing olanzapine treatment and seven (25%) had an episode of vomiting recorded. During 95 total cycles of chemotherapy with olanzapine (mean = 3.4 cycles per patient), there were 21 incidents of nausea (22.1%) and 10 instances of vomiting (10.5%). Side effects were rarely noted. These data suggest that olanzapine was well tolerated and may reduce the incidence of delayed emesis in patients receiving moderate to highly emetogenic chemotherapy. A series of prospective trials are underway.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0885-3924(03)00078-2

Cites

13 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Cited by

See all 56

Metadata

Authors
Passik, S. D., Kirsh, K. L., Theobald, D. E., Dickerson, P., Trowbridge, R., Gray, D., Beaver, M., Comparet, J., & Brown, J.
Affiliations
University of Kentucky (US)
Corresponding author
Passik, Steven D
Venue
Journal of Pain and Symptom Management
Publisher
Elsevier BV
Published
2003-05
Volume
25
Issue
5
Pages
485-488
ISSN
0885-3924 (ISSN-L)
OpenAlex
W2143726677
Cited by
56
References
13
Citations by year
2023: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 3
FWCI
2.03
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Pain and Symptom Management (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Nausea and vomiting management
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
olanzapine, delayed emesis, chemotherapy-induced nausea and vomiting, antiemetic prophylaxis, highly emetogenic chemotherapy, antipsychotic drugs, cancer patients, nausea and vomiting
MeSH terms
Olanzapine, Adult, Aged, Aged, 80 and over, Antiemetics, Antineoplastic Agents, Benzodiazepines, Female, Humans, Male, Middle Aged, Neoplasms, Pirenzepine, Retrospective Studies, Time Factors, Vomiting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients. https://app.cochat.ai/papers/10.1016/s0885-3924(03)00078-2
The paper
Passik, S. D., Kirsh, K. L., Theobald, D. E., Dickerson, P., Trowbridge, R., Gray, D., Beaver, M., Comparet, J., & Brown, J. (2003). A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients. Journal of Pain and Symptom Management. https://doi.org/10.1016/s0885-3924(03)00078-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.